Similarly, in patients with type 2 diabetes and MASH, Hedjazifar et al. have found increased Gremlin-1 expression and a positive correlation with liver steatosis, inflammation, ballooning, and the stage of fibrosis (Hedjazifar et al., 2020). The gene discussed is GREM1; the disease is metabolic dysfunction-associated steatohepatitis.